Cancer Institute A national cancer institute
designated cancer center

Need assistance? Contact the Stanford Cancer Clinical Trials Office at 650-498-7061 or ccto-office@stanford.edu.
Ofrecemos Asistencia en Español.


Search all open clinical trials at Stanford online.

New mobile clinical
trial search app!

iTunes | Google Play


Are you thinking of entering a clinical trial? Learn more here.

Español | 中文 | Pусский


View stories from Cancer Clinical Trial participants at Stanford.

Español | 中文 | Pусский

   

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

This is a first-in-human study to evaluate the safety and anticancer activity of AGS67E. If results are encouraging, study will lead to development of a novel therapy regimen for patients who have not responded to the current standard of care.


Stanford Medicine Resources:

Footer Links: